Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

HLA-Class I Alleles Impact Susceptibility To EBV + Classical Hodgkin Lymphoma By Altering EBV Latent Antigen-Specific CD8 + T-Cell Immune Hierarchies

Maher K Gandhi, Rebekah M Brennan, Leesa Wockner, Pratip K Chattopadhyay, PhD, Mario Roederer, PhD, David A. Price, MD, PhD, David K Cole, PhD, Brekhna Hassan, Konrad Beck, Alycia Thornton, David Gottlieb, MB, PhD, FRCPA, FRACP, David Ritchie, MBBS, PhD, FRACP, FRCPA, John F Seymour, MBBS, PhD, FRACP, Gayathri Kumarasinghe, MB BS, FRACP, Scott R Burrows, PhD, Kimberley Jones, BSc

Blood (2013) 122 (21): 630.

https://doi.org/10.1182/blood.V122.21.630.630

Published: 2013

Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Blood (2010) 116 (21): 16.

https://doi.org/10.1182/blood.V116.21.16.16

Published: 2010

Journal Articles

Allogeneic Virus-Specific T Cells with HLA Alloreactivity Do Not Produce Graft-Versus-Host Disease In Human Subjects

J. Joseph Melenhorst, PhD, Ann M. Leen, PhD, Catherine M. Bollard, MBChB, MD, Máire F Quigley, PhD, David A Price, MD, PhD, Cliona M Rooney, PhD, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath, A. John Barrett, MD, Helen E. Heslop, MD

Blood (2010) 116 (21): 1252.

https://doi.org/10.1182/blood.V116.21.1252.1252

Published: 2010

Journal Articles

Engineering of Human T-Cells with a Novel Aurora-A Kinase-Specific T-Cell Receptor Gene Transfer Confers Anti-Leukemia Reactivity

Kozo Nagai, MD, Hiroshi Fujiwara, MD, PhD, Toshiki Ochi, MD, PhD, Jun An, MD, Toshiaki Shirakata, MD, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD, Hiroshi Shiku, MD, PhD, J. Joseph Melenhorst, PhD, Emma Gostic, David A Price, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2010) 116 (21): 4290.

https://doi.org/10.1182/blood.V116.21.4290.4290

Published: 2010

Journal Articles

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

J. Jopseph Melenhorst, PhD, Phillip Scheinberg, MD, Pratip K. Chattopadhyay, PhD, Emma Gostick, BS, Mario Roederer, PhD, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 2763.

https://doi.org/10.1182/blood.V110.11.2763.2763

Published: 2007

Journal Articles

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, Emma Gostick, BS, Pratip K. Chattopadhyay, PhD, Anna Lissina, BS, David K. Cole, PhD, Mario Roederer, PhD, Ethan Bornstein, MS, Nancy F. Hensel, BS, Daniel C. Douek, MD, PhD, Andrew K. Sewell, PhD, A. John Barrett, MD, David A. Price, MD, PhD

Blood (2007) 110 (11): 1343.

https://doi.org/10.1182/blood.V110.11.1343.1343

Published: 2007

Journal Articles

PR1-Specific T Cell Responses in the First Months Following T-Cell Depleted Allogeneic Stem Cell Transplantation Occur in Both Myeloid and Non-Myeloid Malignancies but Are Only Associated with a GVL Effect in Myeloid Leukemias.

Katayoun Rezvani, MD, PhD, Yong Agnes, MD, PhD, Rhoda B. Eniafe, Stephan Mielke, MD, Bipin N. Savani, MD, David A. Price, MD, PhD, Emma Gostick, Daniel C. Douek, MD, PhD, John M. Goldman, MD, A. John Barrett, MD

Blood (2006) 108 (11): 5195.

https://doi.org/10.1182/blood.V108.11.5195.5195

Published: 2006

Journal Articles

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Katayoun Rezvani, MD, PhD, Agnes Yong, MD, PhD, Stephan Mielke, MD, Bipin N. Savani, MD, David A. Price, MD, PhD, Emma Gostick, Daniel C. Douek, MD, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 3679.

https://doi.org/10.1182/blood.V108.11.3679.3679

Published: 2006

Journal Articles

Widening the Applicability of Human Neutrophil Elastase and Proteinase 3 Peptide Vaccines by Elucidating Immunogenic Non-HLA-A2 MHC Class I Restricted Epitopes.

Rachel E. Hewitt, BSc (Hons), J. Joseph Melenhorst, PhD, David A. Price, MD,PhD, Emma Gostick, BSc, Nancy F. Hensel, J.P. McCoy, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 3708.

https://doi.org/10.1182/blood.V108.11.3708.3708

Published: 2006

Journal Articles

Acquisition of FOXP3 Expression by Human Effector CD4+ T Cells Is a Natural Consequence of Antigen Recognition.

J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, David R. Ambrozak, Nancy F. Hensel, Daniel C. Douek, MD, PhD, David A. Price, MD, PhD, A. John Barrett, MD

Blood (2006) 108 (11): 870.

https://doi.org/10.1182/blood.V108.11.870.870

Published: 2006

Journal Articles

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Ruth Seggewiss, MD, Karin Lore, PhD, Elisabeth Greiner, PhD, Magnus K. Magnusson, MD, David A. Price, MD PhD, Daniel C. Douek, MD PhD, Cynthia E. Dunbar, MD, Adrian Wiestner, MD PhD

Blood (2004) 104 (11): 1342.

https://doi.org/10.1182/blood.V104.11.1342.1342

Published: 2004

NARROW

HLA-Class I Alleles Impact Susceptibility To EBV + Classical Hodgkin Lymphoma By Altering EBV Latent Antigen-Specific CD8 + T-Cell Immune Hierarchies

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Allogeneic Virus-Specific T Cells with HLA Alloreactivity Do Not Produce Graft-Versus-Host Disease In Human Subjects

Engineering of Human T-Cells with a Novel Aurora-A Kinase-Specific T-Cell Receptor Gene Transfer Confers Anti-Leukemia Reactivity

High Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells Preferentially Localize to the Bone Marrow in Patients with Myeloid Malignancies.

Peptide-Major Histocompatibility Complex Class I Tetramers with Enhanced Coreceptor Binding Properties Enable Visualization of Low Avidity Leukemia-Associated Antigen-Specific CD8 + T Cells.

PR1-Specific T Cell Responses in the First Months Following T-Cell Depleted Allogeneic Stem Cell Transplantation Occur in Both Myeloid and Non-Myeloid Malignancies but Are Only Associated with a GVL Effect in Myeloid Leukemias.

WT1-Specific CD8+ T Lymphocytes May Participate in the Elimination of Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.

Widening the Applicability of Human Neutrophil Elastase and Proteinase 3 Peptide Vaccines by Elucidating Immunogenic Non-HLA-A2 MHC Class I Restricted Epitopes.

Acquisition of FOXP3 Expression by Human Effector CD4+ T Cells Is a Natural Consequence of Antigen Recognition.

Proliferation of CD8 + T-Cells Specific for CMV and EBV in Response to TCR Mediated Recognition of Cognate Antigen Is Inhibited by Imatinib in a Dose-Dependent Manner.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only